JP2008526749A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526749A5 JP2008526749A5 JP2007549507A JP2007549507A JP2008526749A5 JP 2008526749 A5 JP2008526749 A5 JP 2008526749A5 JP 2007549507 A JP2007549507 A JP 2007549507A JP 2007549507 A JP2007549507 A JP 2007549507A JP 2008526749 A5 JP2008526749 A5 JP 2008526749A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- membrane
- pharmaceutical composition
- self
- biologically compatible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 32
- 239000012528 membrane Substances 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 150000001768 cations Chemical class 0.000 claims 5
- 229910052751 metal Inorganic materials 0.000 claims 5
- 239000002184 metal Substances 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- 238000001338 self-assembly Methods 0.000 claims 3
- 239000012736 aqueous medium Substances 0.000 claims 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 210000003041 ligament Anatomy 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- VVNXEADCOVSAER-UHFFFAOYSA-N lithium sodium Chemical compound [Li].[Na] VVNXEADCOVSAER-UHFFFAOYSA-N 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 210000000944 nerve tissue Anatomy 0.000 claims 1
- 108010091748 peptide A Proteins 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 claims 1
- 210000002435 tendon Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64099805P | 2005-01-04 | 2005-01-04 | |
| US70231805P | 2005-07-26 | 2005-07-26 | |
| PCT/US2005/046768 WO2006073889A2 (en) | 2005-01-04 | 2005-12-29 | Sustained delivery of pdgf using self-assembling peptide nanofibers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526749A JP2008526749A (ja) | 2008-07-24 |
| JP2008526749A5 true JP2008526749A5 (cg-RX-API-DMAC7.html) | 2009-01-22 |
Family
ID=36648006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007549507A Pending JP2008526749A (ja) | 2005-01-04 | 2005-12-29 | 自己アセンブリするペプチドナノファイバーを用いたpdgfの徐放性の送達 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7429567B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1833504A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008526749A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005323062A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2592292A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006073889A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2572964C (en) * | 2004-07-06 | 2018-03-06 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
| US9162005B2 (en) | 2005-04-25 | 2015-10-20 | Arch Biosurgery, Inc. | Compositions for prevention of adhesions and other barrier applications |
| KR20100102750A (ko) * | 2005-04-25 | 2010-09-24 | 메사추세츠 인스티튜트 오브 테크놀로지 | 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법 |
| HUE037994T2 (hu) * | 2006-04-25 | 2018-09-28 | Massachusetts Inst Technology | Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására |
| CA2655933C (en) * | 2006-06-23 | 2014-09-09 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in cancer |
| EP2066697A2 (en) * | 2006-09-26 | 2009-06-10 | Massachusetts Institute of Technology | Modified self-assembling peptides |
| US7696309B2 (en) * | 2006-10-23 | 2010-04-13 | The Brigham And Women's Hospital, Inc. | Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| US9187517B2 (en) | 2006-11-13 | 2015-11-17 | The Brigham And Women's Hospital, Inc. | Methods of promoting cardiac repair using growth factors fused to heparin binding sequences |
| JP5558104B2 (ja) * | 2006-12-11 | 2014-07-23 | スリー−ディー マトリックス, インコーポレイテッド | 心組織の保護および再生のための組成物および方法 |
| US9415084B2 (en) * | 2007-03-14 | 2016-08-16 | Arch Biosurgery, Inc. | Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| CN105435211A (zh) | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
| CN104829714A (zh) | 2008-11-03 | 2015-08-12 | 阿莱斯亚生物疗法股份有限公司 | 特异性地阻滞肿瘤抗原的生物活性的抗体 |
| US20110117195A1 (en) * | 2009-11-18 | 2011-05-19 | National Cheng Kung University | Method for improving myocardial infarction by intramyocardial or transendocardial injection of peptide nanofibers |
| WO2011072482A1 (en) | 2009-12-14 | 2011-06-23 | The University Of Hong Kong | Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
| JP5732691B2 (ja) * | 2010-01-14 | 2015-06-10 | 学校法人同志社 | インスリン製剤 |
| WO2011106234A1 (en) | 2010-02-25 | 2011-09-01 | Provasculon, Inc. | Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| CA2893376A1 (en) | 2011-03-31 | 2012-10-04 | Alethia Biotherapeutics Inc. | Antibodies against kidney associated antigen 1 and antigen binding fragemnts thereof |
| JP6145089B2 (ja) | 2011-06-07 | 2017-06-07 | メソブラスト インターナショナル エスエイアールエル | ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法 |
| AU2013209234B2 (en) | 2012-01-09 | 2017-11-09 | Adc Therapeutics Sa | Method for treating breast cancer |
| WO2014004467A1 (en) | 2012-06-25 | 2014-01-03 | The Brigham And Women's Hospital, Inc. | Selective cartilage therapy |
| US9421245B2 (en) | 2012-06-25 | 2016-08-23 | The Brigham And Women's Hospital, Inc. | Targeted therapeutics |
| US9790264B2 (en) | 2012-06-25 | 2017-10-17 | The Brigham And Women's Hospital, Inc. | Compounds and methods for modulating pharmacokinetics |
| EP2869903B1 (en) | 2012-07-06 | 2018-11-28 | 3-D Matrix Ltd. | Fill-finish process for peptide solutions |
| EP2698162A1 (en) | 2012-08-15 | 2014-02-19 | Credentis AG | Method for producing a composition for treating a tooth lesion |
| JP6118905B2 (ja) * | 2012-09-21 | 2017-04-19 | テクノロヒアス アバンサダス インスピラリア ス.ル.Tecnologias Avanzadas Inspiralia S.L.(25) | 心臓修復パッチの新しいスキャフォールド |
| WO2015027203A1 (en) | 2013-08-22 | 2015-02-26 | Arch Biosurgery, Inc. | Implantable meshes for controlling the movement of fluids |
| EP2853256A1 (en) | 2013-09-25 | 2015-04-01 | Credentis AG | Dental care product for tooth whitening |
| ES2669548T3 (es) | 2013-09-25 | 2018-05-28 | Credentis Ag | Producto de cuidado dental para el blanqueamiento de los dientes |
| DK3116896T3 (en) | 2014-03-10 | 2019-03-18 | 3 D Matrix Ltd | SELF-PREPARING PEPTIME COMPOSITIONS |
| ES3037364T3 (en) | 2014-03-10 | 2025-10-01 | 3 D Matrix Ltd | Sterilization and filtration of peptide compositions |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| CN104497107B (zh) * | 2014-12-08 | 2017-09-19 | 重庆医科大学 | 一种自组装短肽及其在细胞三维培养中的应用 |
| CN104693277B (zh) * | 2015-03-26 | 2018-02-13 | 罗忠礼 | 一种自组装短肽及其在细胞三维培养中的应用 |
| CN105148289B (zh) * | 2015-09-30 | 2018-10-09 | 南京中医药大学 | 一种两亲性寡聚多肽药物结合物 |
| CN105288653B (zh) * | 2015-11-19 | 2018-10-09 | 南京中医药大学 | 一种两亲性寡聚多肽药物结合物 |
| WO2017120092A1 (en) | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
| EP3248590A1 (en) | 2016-05-24 | 2017-11-29 | Credentis AG | Personal dental care product for caries treatment |
| EP3248591A1 (en) | 2016-05-24 | 2017-11-29 | Credentis AG | Method and product for caries treatment |
| CN117085140A (zh) | 2017-12-15 | 2023-11-21 | 立美基股份有限公司 | 表面活性剂肽纳米结构及在药物递送中的用途 |
| JP7466876B2 (ja) * | 2019-02-20 | 2024-04-15 | 国立大学法人東京農工大学 | 自己組織化ペプチド |
| EP3831360A1 (en) | 2019-12-04 | 2021-06-09 | Credentis AG | Personal dental care product for preventing demineralisation |
| US11154470B1 (en) | 2020-07-31 | 2021-10-26 | vVardis AG | Anti-inflammatory and senolytic dental care product with tooth whitening characteristics |
| CN114181295B (zh) * | 2021-12-15 | 2023-07-04 | 湖南大学 | 一种多肽衍生物及其用途、水凝胶及其制备方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5955343A (en) * | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| US5670483A (en) | 1992-12-28 | 1997-09-23 | Massachusetts Insititute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| JPH08508511A (ja) * | 1993-04-29 | 1996-09-10 | ワシントン・ユニバーシテイー | 副行循環の改善への血小板由来成長因子の使用 |
| JPH11506722A (ja) * | 1995-06-07 | 1999-06-15 | ベイラー・カレッジ・オブ・メディスン | 細胞に核酸を送達するための核酸運搬体 |
| WO2001035932A2 (en) * | 1999-11-18 | 2001-05-25 | The Regents Of The University Of Michigan | Sustained drug delivery from structural matrices |
| WO2002062969A2 (en) * | 2001-02-06 | 2002-08-15 | Massachusetts Institute Of Technology | Cellular reprogramming in peptide hydrogel and uses thereof |
| US7449180B2 (en) * | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
| WO2002076344A1 (en) * | 2001-03-23 | 2002-10-03 | Durect Corporation | Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| US7179784B2 (en) * | 2001-07-10 | 2007-02-20 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
| KR20030043780A (ko) | 2001-11-28 | 2003-06-02 | 주식회사 바이오폴리메드 | 생체적합성 비항원성 공중합체와 그 결합체 및 이들의제조방법 |
| US20030139333A1 (en) * | 2002-01-18 | 2003-07-24 | Genetix Pharmaceuticals, Inc. | Methods and compositions for promoting angiogenesis |
| US20040242469A1 (en) * | 2002-05-13 | 2004-12-02 | Lee Richard T. | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof |
| AU2003274900A1 (en) * | 2002-07-15 | 2004-02-02 | Massachusetts Institute Of Technology | Cellular reprogramming in peptide hydrogel and uses thereof |
| JP2004115413A (ja) * | 2002-09-25 | 2004-04-15 | Yasuhiko Tabata | 冠状動脈狭窄または閉塞治療用徐放性製剤 |
| AU2003297282A1 (en) * | 2002-11-14 | 2004-06-15 | Cornell Research Foundation, Inc. | Protection of cardiac myocardium |
| US10100316B2 (en) * | 2002-11-21 | 2018-10-16 | Archemix Llc | Aptamers comprising CPG motifs |
| US7641643B2 (en) * | 2003-04-15 | 2010-01-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
| WO2005014615A2 (en) * | 2003-06-25 | 2005-02-17 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
| CA2572964C (en) * | 2004-07-06 | 2018-03-06 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
-
2005
- 2005-12-29 AU AU2005323062A patent/AU2005323062A1/en not_active Abandoned
- 2005-12-29 US US11/320,468 patent/US7429567B2/en not_active Expired - Fee Related
- 2005-12-29 CA CA002592292A patent/CA2592292A1/en not_active Abandoned
- 2005-12-29 JP JP2007549507A patent/JP2008526749A/ja active Pending
- 2005-12-29 EP EP05855348A patent/EP1833504A4/en not_active Withdrawn
- 2005-12-29 WO PCT/US2005/046768 patent/WO2006073889A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI480069B (zh) | 用以改善心肌梗塞之醫藥組成物 | |
| JP2023098946A5 (cg-RX-API-DMAC7.html) | ||
| TW570805B (en) | Water-soluble pharmaceutical composition in an ionic complex | |
| JP2005506340A5 (cg-RX-API-DMAC7.html) | ||
| CN1191826C (zh) | 药物制剂 | |
| JP2011519867A5 (cg-RX-API-DMAC7.html) | ||
| CA2452923A1 (en) | Peptide-based compounds for targeting integrin receptors | |
| RU99118890A (ru) | Водорастворимая фармацевтическая композиция в виде ионного комплекса и ее применение | |
| CN1956735A (zh) | 用于增强治疗剂黏膜吸收的递送剂 | |
| WO2006073889A3 (en) | Sustained delivery of pdgf using self-assembling peptide nanofibers | |
| JP2008513513A5 (cg-RX-API-DMAC7.html) | ||
| JP2013535494A5 (cg-RX-API-DMAC7.html) | ||
| JP2004527469A5 (cg-RX-API-DMAC7.html) | ||
| JP7265303B2 (ja) | テリパラチドを含む経口用薬学組成物及びその製造方法 | |
| CN1879888B (zh) | 透皮给药增强剂及其使用方法 | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| CN112826794B (zh) | 一种靶向修复神经血管病变的纳米复合物及其制备与应用 | |
| RU2006131553A (ru) | Комбинация(а) ингибитора топоизомеразы днк и (б) ингибитора iap | |
| ES2822598T3 (es) | Métodos y composiciones para tratar enfermedades y trastornos musculares | |
| RU2011131772A (ru) | Генерируемые в результате инсульта усилители ангиогенеза и их применение | |
| ES2296529A1 (es) | Composicion farmaceutica con promotores de absorcion. | |
| JP4931306B2 (ja) | 骨形成を安全に促進させる医薬複合剤 | |
| CN1222310C (zh) | 肝实质细胞增殖因子药用制剂 | |
| JP2005508875A5 (cg-RX-API-DMAC7.html) | ||
| JP5103748B2 (ja) | 医薬組成物 |